Prognostic Value of Dynamic Contrast-Enhanced MRI-Derived Pharmacokinetic Variables in Glioblastoma Patients: Analysis of Contrast-Enhancing Lesions and Non-Enhancing T2 High-Signal Intensity Lesions.
Yeonah KangEun Kyoung HongJung Hyo RhimRoh-Eul YooKoung Mi KangTae Jin YunJi Hoon KimChul-Ho SohnSun Won ParkSeung Hong ChoiPublished in: Korean journal of radiology (2020)
Among the pharmacokinetic variables extracted from CELs and NE-T2HSILs on preoperative DCE MR imaging, the mean Ktrans of CELs exhibits potential as a useful imaging predictor of PFS in GBM patients.